GlassScriptPhysician profile
Juan R Rivera
NPI 1780682047
$2,107.99
in general payments reported to CMS, 2019-2025
32 companies · $46.87 in 2025
The $46.87 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $72.83 · 2021: $200 · 2022: $385 · 2023: $781 · 2024: $464 · 2025: $46.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $355.12 | 2019-2024 | |
| Novo Nordisk INC | $201.05 | 2019-2024 | Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $147.37 | 2020-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $133.66 | 2021-2024 | |
| Lilly USA, LLC | $125.67 | 2019-2024 | Mounjaro, Trulicity, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.29 | 2020-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $96.42 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.80 | 2022 | |
| Amgen INC. | $69.61 | 2022-2024 | Evenity, Otezla, Repatha |
| Dexcom, INC. | $64.61 | 2022-2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $62.13 | 2022-2024 | Freestyle Libre |
| Abbvie INC. | $60.59 | 2023 | Qulipta, Ubrelvy |
| Esperion Therapeutics, INC. | $49.90 | 2021-2024 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.22 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $48.13 | 2019-2024 | Breztri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $46.87 | 2025 | Evkeeza |
| Amarin Pharma, INC. | $42.97 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $40.59 | 2023 | Eliquis |
| Exact Sciences Corporation | $40.04 | 2024 | Cologuard Collection Kit |
| Lifescan, INC. | $34.37 | 2022 | |
| Siemens Medical Solutions USA, INC. | $32.33 | 2021 | |
| Xeris Pharmaceuticals, INC. | $24.25 | 2022 | |
| Merck Sharp & Dohme LLC | $23.54 | 2024 | Vaxneuvance, Capvaxive, Gardasil |
| Sanofi Pasteur INC. | $23.36 | 2023 | |
| Daiichi Sankyo INC. | $20.04 | 2024 | Injectafer |
| Ge Healthcare | $19.62 | 2023 | |
| Nevro Corp. | $18.52 | 2024 | Senza |
| Boston Scientific Corporation | $18.03 | 2023 | Watchman Access System |
| Astellas Pharma US INC | $17.77 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.04 | 2020 | |
| Medtronic, INC. | $16.64 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.44 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.